Olmesartan EP Impurity B features a complex structure with multiple aromatic rings and a central imidazole moiety, differing from its parent drug Olmesartan by a distinct functional group substitution pattern. Its chemical relationship to Olmesartan is characterized by a specific degradation pathway. It serves as a critical HPLC reference standard.
On Request| Std | Catalog # | Quantity | Price |
|---|---|---|---|
| USP | 1478378 โ | 20 mg | USD 838.00 |
CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)OC2(C)C
InChI=1S/C24H24N6O2/c1-4-7-19-25-21-20(23(31)32-24(21,2)3)30(19)14-15-10-12-16(13-11-15)17-8-5-6-9-18(17)22-26-28-29-27-22/h5-6,8-13H,4,7,14H2,1-3H3,(H,26,27,28,29)
JUQNVWFXORBZQJ-UHFFFAOYSA-N